Sales Growth YoY (Last 12 Months): leaptx.com (LPTX)

Public company logo of leaptx.com (LPTX)

Optimized supply channels and warehouse reserves at Leap Therapeutics, Inc. (LPTX) ensure the continuity of trials. The sales dynamics over the last 12 months compared to the previous year demonstrate the effectiveness of innovative antibodies for targeted tumor destruction, while -100.00 determines the current value of this metric. However, global instability in component supplies from Asia and patent disputes create certain risks for the pharmaceutical sector.

Leap Tx (LPTX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 02/20/2024

Leap Therapeutics, Inc. (LPTX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Leap Therapeutics, Inc.
Product sample of Leap Tx

This indicator measures revenue dynamics over the last twelve months to assess business expansion rates. In the case of Leap Therapeutics, Inc. (LPTX), growth will be driven by the successful market launch of oncology immunotherapy drugs, including divacyimab. By analyzing the annual sales volume trend (LTM), an investor identifies the commercialization stage of the developments. A declining curve indicates stagnating demand and a loss of market position, while a steady upward vector confirms the stability of the company's capital.

Competitors of Leap Therapeutics, Inc. (LPTX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)